IP Library Granted Patent US 10,899,792
Granted Patent B2
US 10,899,792 · App. 16/324,280 · Granted Jan 26, 2021

Production method for insoluble recombinant protein aggregate

Inventors: Toshiaki Osawa (Yamagata, JP); Yuya Sato (Yamagata, JP); Keisuke Morita (Yamagata, JP)
Assignee: Spiber Inc.
C07K1/34C07K1/14C07K1/30C12P21/00C12P21/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,899,792
App. No.
16/324,280
Granted
Jan 26, 2021
Kind
B2
Abstract

An object of the present invention is to provide a method for efficiently separating insoluble bodies of a recombinant protein from a recombinant cell expressing a target recombinant protein as insoluble bodies in the cell. The present invention provides a method for producing a recombinant protein aggregate by separating insoluble bodies of a recombinant protein from a recombinant cell expressing the recombinant protein as insoluble bodies in the cell, including disrupting the recombinant cell, aggregating the insoluble bodies of the recombinant protein, and separating the resulting aggregate.

Claims (25)

1. A method for producing a recombinant protein aggregate, comprising the following steps (A) to (C):

a step (A) of disrupting a recombinant cell expressing a target recombinant protein as insoluble bodies in the cell to obtain a disrupted suspension containing the insoluble bodies of the recombinant protein;

a step (B) of adding one or more selected from the group consisting of a metal salt, an acid, and an anionic flocculant to the disrupted suspension obtained in the step (A), and aggregating the insoluble bodies of the recombinant protein to obtain the recombinant protein aggregate; and

a step (C) of separating the aggregate obtained in the step (B) from the suspension, wherein the recombinant protein is not substantially dissolved in the disrupted suspension.

2. The method for producing a recombinant protein aggregate according to claim 1 , further comprising:

separating the recombinant protein aggregate by a centrifugal force of 10,000×g or less.

3. The method for producing a recombinant protein aggregate according to claim 1 , further comprising:

separating the recombinant protein aggregate by using a centrifuge selected from the group consisting of a separation plate type centrifuge, a basket type centrifuge, and a decanter type centrifuge.

4. The method for producing a recombinant protein aggregate according to claim 1 , further comprising:

separating the recombinant protein aggregate by spontaneous sedimentation or filtration.

5. The method for producing a recombinant protein aggregate according to claim 1 , further comprising:

heating in the step (B).

6. The method for producing a recombinant protein aggregate according to claim 5 , further comprising:

stirring in the step (B).

7. The method for producing a recombinant protein aggregate according to claim 1 , wherein the metal salt is a metal salt selected from the group consisting of an alkaline earth metal salt and an earth metal salt.

8. The method for producing a recombinant protein aggregate according to claim 7 , wherein the metal salt is a metal salt selected from the group consisting of an alkaline earth metal halide, an alkaline earth metal nitrate, an alkaline earth metal sulfate, an earth metal halide, an earth metal nitrate, and an earth metal sulfate.

9. The method for producing a recombinant protein aggregate according to claim 1 , wherein the acid is an oxo acid.

10. The method for producing a recombinant protein aggregate according to claim 9 , wherein the oxo acid is an oxo acid selected from the group consisting of acetic acid, sulfuric acid, and citric acid.

11. The method for producing a recombinant protein aggregate according to claim 1 , wherein the anionic flocculant is an anionic flocculant selected from the group consisting of a polyacrylate, an anionic polyacrylamide, and an acrylamide-acrylate copolymer.

12. The method for producing a recombinant protein aggregate according to claim 1 , wherein the disruption of the recombinant cell is mechanical disruption.

13. The method for producing a recombinant protein aggregate according to claim 1 , wherein the separation of the recombinant protein aggregate is carried out by filtration.

14. The method for producing a recombinant protein aggregate according to claim 1 , wherein the recombinant cell is a recombinant cell transformed with a host selected from the group consisting of a bacterium, a yeast, a filamentous fungus, an insect cell, a plant cell, and an animal cell.

15. The method for producing a recombinant protein aggregate according to claim 1 , wherein the recombinant protein is a structural protein.

16. The method for producing a recombinant protein aggregate according to claim 15 , wherein the structural protein is a protein derived from a protein selected from the group consisting of keratin, collagen, elastin, resilin, silkworm silk, and spider silk.

17. The method for producing a recombinant protein aggregate according to claim 1 , wherein the resulting recombinant protein aggregate has a particle size of 4 μm to 50 μm as measured by an electrical sensing zone method.

Assignments (6)
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 31, 2026
From: GODO KAISHA EVE
To: SPIBER INC.; SPIBER IP MANAGEMENT LLC
Reel/Frame 075350/0864 →
JOINDER AGREEMENT Recorded Dec 29, 2025
From: SPIBER INC.; SPIBER IP MANAGEMENT LLC
To: GODO KAISHA EVE
Reel/Frame 074090/0026 →
IN-KIND CONTRIBUTION AGREEMENT Recorded Dec 29, 2025
From: SPIBER INC.
To: SPIBER IP MANAGEMENT LLC
Reel/Frame 074400/0918 →
SECURITY INTEREST Recorded Oct 14, 2021
From: SPIBER INC.
To: GODO KAISHA EVE
Reel/Frame 057797/0080 →
SECURITY INTEREST Recorded Oct 12, 2021
From: SPIBER INC.
To: GODO KAISHA EVE
Reel/Frame 057766/0444 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2019
From: OSAWA, TOSHIAKI; SATO, YUYA; MORITA, KEISUKE
To: SPIBER INC.
Reel/Frame 048632/0962 →
Priority Claims (4)
JP 2016-157912 · Aug 10, 2016 · national
JP 2016-229227 · Nov 25, 2016 · national
JP 2017-048702 · Mar 14, 2017 · national
JP 2017-094144 · May 10, 2017 · national
Continuity (1)
Related Publication 20190177363A1 · Jun 13, 2019
Cited By (1)
US 12,319,718